News

Peter Thiel's ETHZilla Plunge: From $107 to $3—What Happened?

Peter Thiel's ETHZilla Plunge: From $107 to $3—What Happened?

Billionaire Peter Thiel and Founders Fund just tossed ETHZilla (NASDAQ:ETHZ) out of the portfolio after riding it from an astronomical $107 in August 2025 to a staggering low of $3—a jaw-dropping 97% collapse that’s turned this Ethereum treasury play into a brutal cautionary tale.

The Spectacular Collapse

Thiel's crew grabbed a juicy 7.5% stake when ETHZilla made its pivot from biotech firm 180 Life Sciences to the glitzy world of Ethereum treasury management. You know how it goes—news hit, shares skyrocketed by 90% in one session and broke past that sweet $107 mark. But man, did they pick the wrong moment.

The whole fiasco kicked off on August 18, right after ETHZilla launched its ambitious Ethereum treasury strategy backed by a whopping $565 million capital raise from over 60 investors like Electric Capital and Polychain Capital. At their peak? The company was flexing with over 100,000 ETH tokens stashed away.

Then came October—the crypto crash hit hard. And who was first to react? That’s right—ETHZilla unloaded around $40 million worth of ETH for stock buybacks just to keep the ship afloat. By December, they sold another chunk—24,291 ETH valued at about $74.5 million—to pay down those pesky senior secured convertible notes.

The Business Model Failure

Initially positioned as the “premier Ethereum-focused accumulation vehicle,” promising public market access to ETH while raking in staking yields sounds good on paper—but what happens when prices tank? Well, turns out that model isn't sustainable without rising values. With Ethereum down nearly 60% from its peak in 2025, treasury companies like this find themselves under enormous pressure.

This is where it gets tricky: unlike Michael Saylor’s MSTR, which keeps buying Bitcoin through thick and thin, ETHZilla folded under pressure and started selling off instead.

No surprise here—the company is pivoting again; this time around it's real-world asset tokenization they're chasing. In February alone, they snagged up 95 manufactured home loans for $4.7 million aiming for tokenization on Ethereum Layer 2 alongside two CFM56-7B24 aircraft engines via Liquidity.io. Talk about drastic measures!

The Current Holdings

Fast forward to today: ETHZilla ranks as the sixth-largest corporate holder of Ethereum with approximately 69,802 ETH valued at around $139 million—but let’s get real here—it’s dwarfed by leader BitMine Immersion Technologies (NASDAQ:BMNR), holding a staggering 4,371,497 ETH worth an eye-popping $8.7 billion.

The new narrative? Their future value hinges entirely on revenue growth and cash flow stemming from this RWA tokenization initiative—a far cry from their original mission focused on accumulating Ethereum.

ETHZ Price Update

Current trading action shows ETHZ consolidating between the tight range of $2.50 and $5—talk about straddling volatility! The Bollinger Bands are squished tight—the upper band lurking at $5.64 while the middle sits at around $4.10 and the lower band creeps up at about $2.57—a recipe for potential fireworks ahead!

The RSI has dipped down to an oversold territory reading of 33.78—it seems like selling pressure rules but might be running outta steam soon enough! Critical support levels hover between that crucial range of $2.50-$3; if it breaks below there? Expect further sell-off toward possibly hitting that dreaded low of $2! On the flip side—climbing above that resistance line at around four bucks could signal some upside opportunities coming back into play.

So here's where we land: Thiel's grand investment went belly-up faster than expected as he faced reality crashing hard against initial lofty ambitions—a classic case study amid struggling asset classes ripe for scrutiny across all trading desks watching closely! It’s clear—we're entering turbulent waters where every turn could unleash either doom or glory depending on those earnings reports moving forward or recovery signs flashing green lights across investor screens later this year! Are you ready for what's next as things unfold? Trader playbook: ride out or short those dips?

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cancer Memoir Shows Healing Beyond Medicine

Updated Category News Views 0

Confronting the Unfathomable Out of the North Carolina mountains comes a story that defies expectations—a pastor and farmer named Mark Heisey, who faced the no-holds-barred trials of stage IV-B lymphoma. Now, I'll shoot you straight: this isn't your run-of-the-mill self-help guide or a clinical breakdown of battling cancer. His new memoir dives into the personal and...

Continue Reading
AEVEX Facing Class Action: Deadline Looms for Investors

Updated Category News Views 0

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

Continue Reading
Richard Huffman Joins IFA Board, Strengthens Franchise Ties

Updated Category News Views 2

Ever wonder how the cogs in this massive machine called franchising keep turning? It's folks like Richard Huffman who step up to the plate, and his recent election to the International Franchise Association (IFA) Board of Directors is worth a second glance. Huffman: A Franchise Veteran Now, Huffman isn't some rookie in the world of franchising. You see, back in '94, he...

Continue Reading
Venue Two Eleven: Historic Charm Meets Modern Events

Updated Category News Views 0

Welcome To Venue Two Eleven: Where History Meets Modernity Alright, folks. Let’s talk about Venue Two Eleven—a new joint in town that’s blending the old with the new in a way that’s got me raising an eyebrow and maybe even sipping my coffee a little slower. Nestled in the Museum of the Oregon Territory, this place is pulling double duty as both a window to the...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 65

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 33

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
GELITA Showcases Collagen Innovations at SupplySide 2026

Updated Category News Views 0

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

Continue Reading
U.S. Millionaire Surge: Market Waves or Mirage?

Updated Category News Views 0

Flashing Billions: Minting Millionaires at Breakneck Speed It sounds like something out of an 80s movie: every single day, over 1,200 folks in the United States become millionaires. Yep, you heard right. The UBS Global Wealth Report 2026 threw that number out, and it sure caught my attention. It's not everyday you hear about the U.S. cranking out millionaires like they're...

Continue Reading
Kansai Medical Ushers in New Era of Cancer Research

Updated Category News Views 1

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

Continue Reading
Match2 Enhances HR Tech: Unified Talent Profile System

Updated Category News Views 1

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Continue Reading

Top 5 Most Recently Viewed Articles

Securiti Earns Noteworthy AWS Security Competency in AI

Updated Category News Views 375

Securiti Achieves AWS Security Competency Status in AI Security Securiti, the pioneer of the Data+AI Command Center, proudly announces its recent achievement of Amazon Web Services (AWS) Security Competency status in the innovative AI Security category. This new milestone highlights Securiti as one of the select inaugural partners recognized by AWS for its exceptional...

Continue Reading
Exciting Family Medicine Forum in Winnipeg This Fall

Updated Category News Views 204

Join the Family Medicine Forum in Winnipeg Mark your calendars, as the Family Medicine Forum is heading to Winnipeg this November for an enriching experience that promises to bring together family physicians from across the nation. This premier event is not only a chance to learn but to celebrate the vital work family doctors do every day. The Essence of Family Medicine...

Continue Reading
Man Group PLC Reveals Interest in Dowlais Group Securities

Updated Category News Views 106

Understanding the Disclosure by Man Group PLC In the realm of financial markets, disclosures play a crucial role in maintaining transparency and informing stakeholders about significant market movements. Recently, Man Group PLC made headlines by revealing its position regarding Dowlais Group PLC's relevant securities. This disclosure is essential as it reflects the...

Continue Reading
Experity Welcomes Bobby Ghoshal as New COO and President

Updated Category News Views 371

Experity Welcomes Bobby Ghoshal as President and COO Experity, a leader in on-demand healthcare solutions, has appointed Bobby Ghoshal as its new President and Chief Operating Officer. In this important role, Mr. Ghoshal will spearhead daily operations, steering the strategic direction for the company. His appointment is pivotal in enhancing Experity's mission to serve...

Continue Reading
LifeMD's Upcoming Engagements at Major Investor Conferences

Updated Category News Views 96

LifeMD's Upcoming Engagements at Major Investor Conferences LifeMD, Inc. (Nasdaq: LFMD), a trailblazer in virtual primary care, has recently announced its participation in several prominent investor conferences this September. As a company recognized for its innovative approach in telemedicine, LifeMD’s management is eager to showcase their vision and accomplishments to...

Continue Reading